[1] F. F. J€obsis, "Noninvasive, infrared monitoring of cerebral and myocardial oxygen su±ciency and circulatory parameters," Science 198(4323), 1264–1267 (1977).

[2] A. Puttipipatkajorn, A. Puttipipatkajorn, "Development of calibration models for rapid determination of moisture content in rubber sheets using portable near-infrared spectrometers," J. Innov. Opt. Health Sci. 13(2), 2050009 (2020).

[3] K. S. Hong, M. A. Yaqub, "Application of functional near-infrared spectroscopy in the healthcare industry: A review," J. Innov. Opt. Health Sci. 12(6), 1930012 (2019).

[4] S. Lancia, J. Choi, J. Baek, S. Mammarella, D. Bianco, V. Quaresima, M. Ferrari, "Trail making test induces prefrontal cortex activation as revealed by a CW wearable-wireless fNIRS/DOT imager. Oxygen transport to tissue XL," Adv. Exp. Med. Biol. 1072, 139–144 (2018).

[5] J. Y. Sun, L. S. Rao, C. Y. Gao, "Extracting heartrate from optical signal of functional near- infrared spectroscopy based on mathematical morphology," J. Innov. Opt. Health Sci. 11(3), 1850010 (2018).

[6] M. Izzetoglu, R. Holtzer, "Effects of processing methods on fNIRS signals assessed during active walking tasks in older adults," IEEE Trans. Neural Syst. Rehabil. Eng. 28(3), 699–709 (2020).

[7] T. Liu, X. Liu, L. Yi, C. Zhu, P. S. Markey, M. Pelowski, "Assessing autism at its social and developmental roots: A review of Autism Spectrum Disorder studies using functional near-infrared spectroscopy," NeuroImage 185, 955–967 (2017).

[8] J. E. Kim, G. H. Kim, J. Hwang, J. Y. Kim, P. F. Renshaw, D. A. Yurgelun-Todd, S. Yoon, "Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users," Addict. Biol. 23(1), 327–336 (2016).

[9] I. K. Lyoo, S. Yoon, T. S. Kim, S. M. Lim, Y. Choi, J. E. Kim, P. F. Renshaw, "Predisposition to and effects of methamphetamine use on the adolescent brain," Mol. Psychiatry 20(12), 1516–1524 (2015).

[10] J. J. McCarthy, M. H. Leamon, N. H. Willits, R. Salo, "The effect of methadone dose regimen on neonatal abstinence syndrome," J. Addict. Med. 9(2), 105–110 (2015).

[11] A. C. May, R. L. Aupperle, J. L. Stewart, "Dark times: The role of negative reinforcement in methamphetamine addiction," Front. Psychiatry 11, 114 (2020).

[12] M. Kohno, L. E. Dennis, H. McCready, D. L. Schwartz, W. F. Hoffman, P. T. Korthuis, "A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder," Drug Alcohol Depend. 192, 186–192 (2018).

[13] J. Corre, R. van Zessen, M. Loureiro et al., "Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement," eLife 30(10), e39945 (2018).

[14] K. Yuan, L. Cao, Y. X. Xue et al., "Basolateral amygdala is required for reconsolidation updating of heroin-associated memory after prolonged withdrawal," Addict Biol. 25, e12793 (2020).

[15] B. G. Teklezgi, A. Pamreddy, S. Baijnath et al., "Time-dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction," Addict Biol. 24(3), 438–446 (2019).

[16] R. D. Baler, N. D. Volkow, "Drug addiction: The neurobiology of disrupted self-control," Trends Mol. Med. 12(12), 559–566 (2006).

[17] S. A. Morelli, M. D. Sacchet, J. Zaki, "Common and distinct neural correlates of personal and vicarious reward: A quantitative meta-analysis," NeuroImage 112, 244–253 (2015).

[18] P. Li, Y. Huang, L. Guo et al., "Sexual attraction and the nonmedical use of opioids and sedative drugs among Chinese adolescents," Drug Alcohol Depend. 183, 169–175 (2018).

[19] C. Chenaf, J. L. Kabore, J. Delorme et al., "Prescription opioid analgesic use in France: Trends and impact on morbidity - mortality," Eur. J. Pain 23(1), 124–134 (2019).

[20] A. Dragomir, Y. M. Akay, D. Zhang, M. Akay, "Ventral tegmental area dopamine neurons firing model reveals prenatal nicotine induced alterations," IEEE Trans. Neural Syst. Rehabil. Eng. 25(9), 1387–1396 (2017).

[21] B. Fischer, W. Jones, J. Rehm, "Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: An update with a focus on recent interventions," BMC Health Serv. Res. 14(1), 90 (2014).

[22] E. A. Karanges, B. Blanch, N. A. Buckley et al. "Twenty-five years of prescription opioid use in Australia: A whole-of-population analysis using pharmaceutical claims," Br. J. Clin. Pharmacol. 82 (1), 255–267 (2016).

[23] X. Wang, Y. Chen, X. Li et al., "Moderate — intensity aerobic exercise restores appetite and prefrontal brain activity to images of food among persons dependent on methamphetamine: A functional near-infrared spectroscopy study," Front. Hum. Neurosci. 13, 400 (2019).

[24] K. Yamamuro, M. Makinodan, S. Kimoto et al., "Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine induced psychosis and schizophrenia," Sci. Rep. 5(1), 12107 (2015).

[25] J.-M. Kim, J.-K. Choi, M. Choi, M. Ji, G. Hwang, S.-B. Ko, H.-M. Bae, "Assessment of cerebral autoregulation using continuous-wave near-infrared spectroscopy during squat-stand maneuvers in subjects with symptoms of orthostatic intolerance," Sci. Rep. 8(1), 13257 (2018).

[26] A. N. Perry, R. J. Ortiz, K. R. Hernandez, B. S. Cushing, "Effects of methamphetamine on alloparental behavior in male and female prairie voles," Physiol. Behav. 203, 128–134 (2019).

[27] J. Zhao, A. H. Kral, K. A. Simpson, R. C. Ceasar, L. D. Wenger, M. Kirkpatrick and R. N. Bluthenthal, "Factors associated with methamphetamine withdrawal symptoms among people who inject drugs," Drug Alcohol Depend. 223, 108702 (2021).

[28] T. J. Cicero, M. S. Ellis, Z. A. Kasper, "Polysubstance use: A broader understanding of substance use during the opioid crisis," Am. Public Health Assoc. 110(2), 244–250 (2020).

[29] J. Du, C. L. Fan, H. F. Jiang, H. M. Sun, X. Li, M. Zhao, "Biofeedback combined with cue-exposure as a treatment for heroin addicts," Physiol. Behav. 130, 34–39 (2014).

[30] G. A. Angarita, D. Matuskey, B. Pittman, J. L. Costeines, M. N. Potenza, A. M. Jastreboff, H. D. Schmidt, R. T. Malison, "Testing the effects of the GLP-1 receptor agonist exenatide on cocaine selfadministration and subjective responses in humans with cocaine use disorder," Drug Alcohol Depend. 221, 108614 (2021).

[31] P. J. Adams, M. Rychert, C. Wilkins, "Policy in-fluence and the legalized cannabis industry: Learnings from other addictive consumption industries," Addiction 116(11), 2939–2946 (2021).

[32] M. McGregor, M. Hamilton, J. Hajnal, A. Thanos, "Roux-en-Y gastric bypass increases GABA-A receptor levels in regions of the rat brain involved in object recognition memory and perceptual acuity," Physiol. Behav. 224, 113053 (2020).